Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial (Q33881449)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

1 reference

based on heuristic

inferred from title

31

object named as

Helen Rees

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

39

object named as

Connie Celum

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Partners in Prevention HSV/HIV Transmission Study Team

40

object named as

Partners in Prevention HSV/HIV Transmission Study Team

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kayitesi Kayitenkore

27

object named as

Kayitesi Kayitenkore

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

38

object named as

Lawrence Corey

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

15

object named as

Joseph Makhema

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

object named as

Saidi Kapiga

23

0 references

object named as

Anna Wald

3

0 references

object named as

Allan Ronald

11

0 references

10

object named as

Elly Katabira

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Elizabeth Bukusi

8

object named as

Elizabeth A Bukusi

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

object named as

Craig R Cohen

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

28

object named as

Etienne Karita

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

13

object named as

Carey Farquhar

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

20

object named as

Glenda E Gray

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

37

object named as

Renee Ridzon

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2

object named as

Jared M Baeten

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jairam R Lingappa

1

object named as

Jairam R Lingappa

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

7

object named as

Nelly Mugo

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Bellington Vwalika

32

object named as

Bellington Vwalika

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

35

object named as

Lara Kidoguchi

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Andrew Mujugira

6

object named as

Andrew Mujugira

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Grace John-Stewart

14

object named as

Grace John Stewart

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Amalia S Magaret

33

object named as

Amalia S Magaret

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

12

object named as

James Kiarie

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

17

object named as

Edwin Were

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

22

object named as

Rachel Manongi

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

24

object named as

David Coetzee

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mubiana Inambao

26

object named as

Mubiana Inambao

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

William Kanweka

29

object named as

William Kanweka

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sinead Delany-Moretlwe

30

object named as

Sinead Delany

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

19

object named as

Guy de Bruyn

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Katherine K Thomas

5

object named as

Katherine K Thomas

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

36

object named as

Linda Barnes

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

16

object named as

Myron Essex

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

James P Hughes

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kenneth H Fife

18

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

James A McIntyre

21

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Susan Allen

25

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Richard S Wang

34

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

12 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

375

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9717

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

824-833

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Genital herpes: antiviral therapy for symptom relief and prevention of transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

A randomized trial of multivitamin supplements and HIV disease progression and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Epidemiology of herpes simplex virus type 2 infection in the developing world

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Herpes simplex virus infection induces replication of human immunodeficiency virus type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Calculating the number needed to treat for trials where the outcome is time to an event

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

5 July 2018

Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

The impact of active herpes simplex virus infection on human immunodeficiency virus load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877592

29 October 2018

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962038-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CP

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962038-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962038-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Efficiency of Cox's Likelihood Function for Censored Data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962038-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962038-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962038-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)62038-9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33881449&oldid=2032346614"